DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel (CMP) Testing Market Analysis by Disease Type (Diabetes, Kidney Disease, Liver Disease), by End User (Point Of Contact (PoC), Laboratories), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global comprehensive metabolic panel (CMP) testing market size is estimated to be USD 12.5 billion … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global interventional neurology market size is estimated to be USD 2,702.4 … [Read more…]

Agenda Includes Improving the Participant Experience, Post-Pandemic Employee Benefit Perceptions, and Diversity, Equity, and Inclusion Initiatives WASHINGTON–(BUSINESS WIRE)–ECFC, the leading nonprofit organization promoting choice in consumer-driven benefit solutions, will hold its 35th Annual Symposium on August 3-5 to educate benefits industry professionals on evolving healthcare trends in a post-pandemic healthcare environment. The 35th Annual Symposium … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Brain Cancer Treatment Drugs Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that ALBRIOZA™ (sodium phenylbutyrate and ursodoxicoltaurine) is now commercially available in Canada for people living with amyotrophic lateral sclerosis (ALS). ALBRIOZA (also known as AMX0035) is an oral fixed-dose combination therapy that may reduce neuronal cell death as a stand-alone therapy or … [Read more…]

Expanding access to affordable oncology medicines LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today it has introduced Thiotepa for Injection, USP, in the United States. Thiotepa, a generic equivalent to Tepadina®, is the newest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. Fresenius Kabi Thiotepa for Injection, USP is available … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance Auditing and Inspections Course” training has been added to ResearchAndMarkets.com’s offering. This seminar will also focus on the risk base approaches in response to COVID – 19 including recent legislation governing the conduct of these activities. PV Audit Strategy Planning course will provide an overview of the European Medicines Agency’s (EMA) … [Read more…]

–– Enrollment of PNH Patients Expected to Begin this Summer — SEATTLE–(BUSINESS WIRE)–Omeros Corporation today announced that OMS906 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). OMS906 targets mannan-binding lectin-associated serine protease-3 (MASP-3), the key activator of the alternative pathway of the … [Read more…]

Good Neighbor Pharmacy also achieved the highest score with the “My Level of Trust with Pharmacy” factor, indicating exceptional patient confidence CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Good Neighbor Pharmacy (GNP), a national independent pharmacy network offered through AmerisourceBergen, today announced that it has been ranked “Highest in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D. Power … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Friday, August 5, 2022 to report financial results for the quarter ended June 30, 2022 and discuss recent corporate highlights. The dial-in numbers are (844) 200-6205 for domestic callers and (929) 526-1599 for international callers. The access code … [Read more…]